Vir Biotechnology (VIR) Other Working Capital Changes (2018 - 2026)

Vir Biotechnology has reported Other Working Capital Changes for 7 years, with the latest figure at -$2.3 million in Q1 2026.

• Quarterly Other Working Capital Changes fell 26.56% year-over-year to -$2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.8 million (up 62.2% YoY) and the FY2025 annual result came in at -$7.4 million, up 68.0% from the prior year.
• Other Working Capital Changes advanced to -$2.3 million in Q1 2026 per VIR's latest filing, from -$2.3 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $51.0 million in Q2 2024 and troughed at -$50.2 million in Q1 2024.
• A 5-year average of -$992058.8 and a median of -$14000.0 in 2023 frame the typical range for Other Working Capital Changes.
• The widest YoY moves for Other Working Capital Changes: up 1000.0% in 2022, down 9492.31% in 2022.
• Over 5 years, Other Working Capital Changes stood at $2.2 million in 2022, then sank by 244.92% to -$3.1 million in 2023, then tumbled by 301.63% to -$12.6 million in 2024, then jumped by 81.56% to -$2.3 million in 2025, then climbed by 2.15% to -$2.3 million in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$2.3 million, -$2.3 million, and -$1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.